Table 6

Insulin resistance and inflammatory biomarker concentrations at baseline and at 3 and 6 month in elderly patients exclusively receiving a protein-enriched enteral diet

0 mo

3 mo

6 mo

P*


Insulin (mU/L)

3.12 ± 0.65

6.30 ± 1.32

4.62 ± 0.99

0.066

HOMA-IR

0.65 ± 0.13

1.41 ± 0.31

0.95 ± 0.20

0.087

Adiponectin (mg/mL)

18.7 ± 1.5

19.0 ± 1.6

20.3 ± 2.3

0.926

C-reactive protein (mg/L)

1.26 ± 0.44

1.58 ± 0.58

0.91 ± 0.28

0.886

Interleukin 6 (ng/L)

20.65 ± 4.10

29.36 ± 8.45

17.69 ± 6.29

0.424

Tumor Necrosis Factor alpha (ng/L)

4.28 ± 0.44a

4.53 ± 0.44a

5.42 ± 0.46b

0.007

Interleukin 8 (ng/L)

6.35 ± 0.94

6.62 ± 1.88

5.38 ± 1.39

0.165


HOMA-IR, homeostasis model assessment for insulin resistance.

* Differences between times were analyzed using the Friedman test, considering P < 0.05 to be significant.

x ± SEM (for all values).

Differences between times were analyzed using the Wilcoxon test, considering P < 0.05 to be significant. In each group, mean values within the same row with unlike superscript letters were significantly different.

Olza et al. Nutrition & Metabolism 2010 7:58   doi:10.1186/1743-7075-7-58

Open Data